
Results
4
Most Popular Stocks on the market
4 companies
AFT Pharmaceuticals
Market Cap: NZ$367.0m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$3.40
7D
-2.9%
1Y
29.8%
Pacific Edge
Market Cap: NZ$188.2m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.18
7D
-7.1%
1Y
45.6%
BLIS Technologies
Market Cap: NZ$19.2m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.015
7D
0%
1Y
7.1%
Rua Bioscience
Market Cap: NZ$11.2m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.031
7D
-6.1%
1Y
6.9%